The urea breath test market involves medical tests used to detect active Helicobacter pylori (H. pylori) infection in the stomach and duodenum. H. pylori bacteria can cause gastritis, peptic ulcers, and increase the risk of stomach cancer if left untreated. The urea breath test, also known as the C-urea breath test, is a noninvasive diagnostic technique to identify active H. pylori infection. It involves taking a breath sample before and after drinking a liquid that contains urea marked with carbon-13 or carbon-14 isotopes. If H. pylori is present, it will break down the urea and release carbon dioxide in the breath, which can be detected by a mass spectrometer. The test results are received within 30 minutes, providing an easy and accurate diagnosis compared to invasive procedures like endoscopy.

The Global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Urea Breath Test Market Trends are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay & Grain Inc., Bailey Farms, Border Valley, Coaba, Cubeit Hay Company, Glenvar Hay, Green Prairie International, Grupo Osés, Gruppo Carli, Hay USA, Haykingdom Inc., Oregon Hay Products, Inc., Los Venteros SC, M&C Hay, Legal Alfalfa Products Ltd., Riverina (Australia) Pty Ltd, SL Follen Company, and Standlee Hay Company.

The growing demand for non-invasive diagnostic tests for H. pylori infection is a major factor driving the urea breath test market. Urea breath tests are replacing older invasive diagnostic methods like endoscopy as they are painless, provide quicker results, and have a higher patient acceptability.

Key players in the market are focusing on geographical expansion and capacity addition to strengthen their presence across major markets. For instance, in 2022, SL Follen Company inaugurated a new manufacturing plant in Mexico to cater to the growing demand for urea breath tests in Latin American countries.

Market Drivers

The primary driver boosting the urea breath test market growth is the rising incidence of peptic ulcer disease and gastric cancer attributed to H. pylori infection. As per the National Institute of Health, over 50% of the world's population is affected by H. pylori, making reliable diagnosis critical. Secondly, increasing awareness about non-invasive diagnosis and advantages of urea breath tests over traditional endoscopy or stool antigen tests is prompting more physicians to recommend UBT for H. pylori detection. Additionally, availability of medical reimbursement for UBTs in developed countries and growing healthcare expenditure in developing nations are expected to propel the market expansion through 2031.

Get more insights on Urea Breath Test Market